It’s our pleasure to share with you the Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
ALLG News is for people, like you, who are interested in medical research and ALLG’s mission to create better treatments and better lives for patients with blood cancers.
As the only non-profit collaborative clinical trials groups in Australia and New Zealand for blood cancers, the ALLG has the capability to run independent doctor-led clinical trials in Australasia and, crucially, to participate in teletrials and international trials; allowing us access to new treatments, with the potential to make a significant impact on patient outcome.
We hope you enjoy reading about ALLG’s world-leading blood cancer research and the impact your support has for patients with blood cancers.
ALLG News Edition 3
Our teletrials allow greater access for patients living in rural and regional areas of Australia and New Zealander, to participate on clinical trials; including patients just like Cairns (Australia) resident Vesselin (Vess) Petkov, an anaesthetist who joined an ALLG clinical trial for the treatment of his Mantle Cell Lymphoma. You can read Vess’ story, and more, in this newsletter.
You can read ALLG News Edition 3 here.
ALLG News Edition 2
Our international clinical trial collaborations bring new treatments to Australians and New Zealanders; including patients just like New Zealander Hemi Frires, a Royal New Zealand Air Force pilot who joined an ALLG clinical trial for the treatment of his Hodgkin Lymphoma. You can read Hemi’s story, and more, in this newsletter.
You can read ALLG News Edition 2 here.
ALLG News Edition 1
The first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News. ALLG launched our community newsletter in September 2022 during Blood Cancer Awareness Month, a critical time to raise awareness of blood cancers such as leukaemia, lymphoma and myeloma.
You can read ALLG News Edition 1 here.